Vesicare
Product Images NDC 51248-151

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vesicare (NDC 51248-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Solifenacin Succinate (Image 01)

Chemical structure of the active ingredient of VESIcare, showing a detailed molecular formula with aromatic rings, a piperidine ring, an ester linkage, and a carboxylic acid component, consistent with solifenacin succinate.*

FDA Label Image

Image 02

Packaging label for VESIcare 5 mg tablets, containing 30 tablets per package. The active ingredient noted is solifenacin succinate. Labeler is Astellas Pharma US, Inc., with product distributed from Northbrook, IL. The label includes dosage instructions denoting once-daily use and storage conditions. The label also features contact information for patient inquiries and barcodes.*

FDA Label Image

Image 03

VESIcare tablets 10 mg packaging label in a flat layout, showing the proprietary name and active ingredient solifenacin succinate. The label indicates a count of 30 tablets and includes dosage information stating the strength as 10 mg per tablet. Marketed and distributed by Astellas Pharma US, Inc., with product origin as Ireland. The label also provides storage instructions and pharmacist dispensing guidelines along with barcodes for scanning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.